137 related articles for article (PubMed ID: 25615773)
21. Challenges and new horizons in the management of advanced basal cell carcinoma: a UK perspective.
Lear JT; Corner C; Dziewulski P; Fife K; Ross GL; Varma S; Harwood CA
Br J Cancer; 2014 Oct; 111(8):1476-81. PubMed ID: 25211660
[TBL] [Abstract][Full Text] [Related]
22. Rodent under the hat.
Lo WB; Richmond L; George KJ; Dardis R
Br J Neurosurg; 2011 Oct; 25(5):662-3. PubMed ID: 21707244
[TBL] [Abstract][Full Text] [Related]
23. Patient-driven management using same-day noninvasive diagnosis and complete laser treatment of basal cell carcinomas: a pilot study.
Markowitz O; Psomadakis CE
Cutis; 2019 Dec; 104(6):345-348;350;351;E1;E2. PubMed ID: 31939924
[TBL] [Abstract][Full Text] [Related]
24. Basal cell carcinoma.
Brooke RC
Clin Med (Lond); 2005; 5(6):551-4. PubMed ID: 16411349
[No Abstract] [Full Text] [Related]
25. Locally Advanced Basal Cell Carcinoma: Two Severe Case Presentations and Review.
Brown L; David J; Skopit S
J Drugs Dermatol; 2018 Mar; 17(3):358-362. PubMed ID: 29537455
[TBL] [Abstract][Full Text] [Related]
26. Basal cell carcinoma of the skin (part 2): diagnosis, prognosis and management.
Correia de Sá TR; Silva R; Lopes JM
Future Oncol; 2015 Nov; 11(22):3023-38. PubMed ID: 26449265
[TBL] [Abstract][Full Text] [Related]
27. Intralesional bevacizumab as in-add adjuvant to immunocryosurgery for locally advanced basal cell carcinoma.
Gaitanis G; Bassukas I
J Eur Acad Dermatol Venereol; 2014 Aug; 28(8):1117-21. PubMed ID: 25243268
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous malignancy in adolescents.
Turvy DN; Mark LA
Adolesc Med State Art Rev; 2011 Apr; 22(1):54-76, viii. PubMed ID: 21815444
[TBL] [Abstract][Full Text] [Related]
29. Burden of basal cell carcinoma in USA.
Wu X; Elkin EE; Marghoob AA
Future Oncol; 2015 Nov; 11(22):2967-74. PubMed ID: 26466906
[TBL] [Abstract][Full Text] [Related]
30. [Comparative study of the results of surgical and radiotherapy treatment of basal cell epitheliomas and prickle cell carcinomas].
Gajewska B; Rukszto A; Jakubowicz K; Kik A
Przegl Dermatol; 1979; 66(1):87-94. PubMed ID: 424625
[No Abstract] [Full Text] [Related]
31. Systemic therapy for disseminated basal cell carcinoma: an uncommon manifestation of a common cancer.
Ganti AK; Kessinger A
Cancer Treat Rev; 2011 Oct; 37(6):440-3. PubMed ID: 21216106
[TBL] [Abstract][Full Text] [Related]
32. Vismodegib for the treatment of basal cell carcinoma: results and implications of the ERIVANCE BCC trial.
Dessinioti C; Plaka M; Stratigos AJ
Future Oncol; 2014 May; 10(6):927-36. PubMed ID: 24941979
[TBL] [Abstract][Full Text] [Related]
33. Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib.
Chang AL; Solomon JA; Hainsworth JD; Goldberg L; McKenna E; Day BM; Chen DM; Weiss GJ
J Am Acad Dermatol; 2014 Jan; 70(1):60-9. PubMed ID: 24189279
[TBL] [Abstract][Full Text] [Related]
34. Perineural invasion of cutaneous squamous cell carcinoma and basal cell carcinoma: raising awareness and optimizing management.
Geist DE; Garcia-Moliner M; Fitzek MM; Cho H; Rogers GS
Dermatol Surg; 2008 Dec; 34(12):1642-51. PubMed ID: 19018830
[TBL] [Abstract][Full Text] [Related]
35. [Skeletal and dermatological manifestations of the nevoid Basal cell carcinoma syndrome (Gorlin-Goltz syndrome). Results of 8 patients in 12 years].
Rupprecht M; Mensing CH; Barvencik F; Ittrich H; Heiland M; Rueger JM; Amling M; Pogoda P
Rofo; 2007 Jun; 179(6):618-26. PubMed ID: 17492539
[TBL] [Abstract][Full Text] [Related]
36. [Basal cell carcinoma].
Takenouchi T
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1398-403. PubMed ID: 17033227
[TBL] [Abstract][Full Text] [Related]
37. A case of antiphospholipid antibody syndrome that manifested in the course of basal cell carcinoma.
Funauchi M; Yamagata T; Sugiyama M; Ikoma SY; Sakaguchi M; Kinoshita K; Kawata A
Mod Rheumatol; 2007; 17(2):153-5. PubMed ID: 17437172
[TBL] [Abstract][Full Text] [Related]
38. Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods.
Kauvar AN; Cronin T; Roenigk R; Hruza G; Bennett R;
Dermatol Surg; 2015 May; 41(5):550-71. PubMed ID: 25868035
[TBL] [Abstract][Full Text] [Related]
39. An unusual case of infiltrating basal cell carcinoma.
Salas-Alanis JC; Kurban M; Cepeda-Valdes R; Chavez-Alvarez S; Christiano AM; Bickers D
Dermatol Surg; 2011 Sep; 37(9):1316-8. PubMed ID: 21679275
[No Abstract] [Full Text] [Related]
40. Ultrasound as predictor of histologic subtypes linked to recurrence in basal cell carcinoma of the skin.
Wortsman X; Vergara P; Castro A; Saavedra D; Bobadilla F; Sazunic I; Zemelman V; Wortsman J
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):702-7. PubMed ID: 25200424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
